Erasmus Medisch Centrum Daniel Den Hoed

Rotterdam 3015 GD

0 studies enrolling now · 2 studies all time

What they study most

Carcinoma, Non-Small-Cell Lung, HER2-positive Breast Cancer

Studies at this site

• A Study of Tucatinib vs. Placebo in Combination With Ado-trastuzumab Emtansine (T-DM1) for Patients With Advanced or Metastatic HER2+ Breast Cancer — Running, not enrolling
• A Study of SGN-B6A Versus Docetaxel in Previously Treated Non-small Cell Lung Cancer — Running, not enrolling